Concepedia

Judy Johnson

JJ

16

Publications

712

Citations

14

H-Index

1996

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Aaron Diamond AIDS Research Center

University of North Carolina at Chapel Hill

University of Colorado Health

Judy Johnson is an author at Research Triangle Park Foundation specializing in medicine, hiv, and immunology.

Top concepts

Publications per year

1996–2007

16

Publications

16

Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV‐Infected Antiretroviral‐Naive Subjects

Joel E. Gallant, Allan Rodríguez, Winkler G. Weinberg et al. · The Journal of Infectious Diseases · 2005 · 146 citations · Full text

Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin

Martin O’Donnell, Clive Kearon, Judy Johnson et al. · Annals of Internal Medicine · 2007 · 108 citations

HIV-1 RNA levels and the development of clinical disease

A. Philips, Joseph J. Eron, John Bartlett et al. · AIDS · 1996 · 90 citations

Long-Term Results of Initial Therapy With Abacavir and Lamivudine Combined With Efavirenz, Amprenavir/Ritonavir, or Stavudine

John Bartlett, Judy Johnson, Gisela Herrera et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 73 citations

Virologic and Immunologic Effect of Antiretroviral Therapy on HIV-1 in Gut-Associated Lymphoid Tissue

Andrew H. Talal, Simon Monard, Mika Vesanen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 47 citations

Rows per page

1–5 of 16